These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4205945)

  • 1. Development of a purified cholera toxoid. I. Purification of toxin.
    Rappaport RS; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):294-303. PubMed ID: 4205945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of Vibrio cholerae virulence: purification of cholera enterotoxin by preparative disc electrophoresis.
    Lewis AC; Richardson SH; Sheridan B
    Appl Environ Microbiol; 1976 Aug; 32(2):288-93. PubMed ID: 987751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and properties of somatic antigen spontaneously released from Vibrio cholerae.
    Pike RM; Chandler CH
    Infect Immun; 1975 Jul; 12(1):187-92. PubMed ID: 806532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.
    Holmgren J
    Infect Immun; 1973 Dec; 8(6):851-9. PubMed ID: 4206342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of a non-o1 Vibrio cholerae enterotoxin that is identical to cholera enterotoxin.
    Yamamoto K; Takeda Y; Miwatani T; Craig JP
    Infect Immun; 1983 Mar; 39(3):1128-35. PubMed ID: 6188694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.
    Gyles CL
    Infect Immun; 1974 Mar; 9(3):564-70. PubMed ID: 4206029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin.
    Yamamoto K; Takeda Y; Miwatani T; Craig JP
    Infect Immun; 1983 Sep; 41(3):896-901. PubMed ID: 6411622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibility of purifying cholera toxin (choleragen) and its antibodies by an immunosorption method].
    Zakrevskii VI; Efremenko VI; Lobanov VV; Dolmatova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):30-4. PubMed ID: 452780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
    Jonson G; Osek J; Svennerholm AM; Holmgren J
    Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of El Tor cholera enterotoxins and comparisons with classical toxin.
    Dubey RS; Lindblad M; Holmgren J
    J Gen Microbiol; 1990 Sep; 136(9):1839-47. PubMed ID: 1704409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Dec; 22(3):709-13. PubMed ID: 83301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of heat-labile enterotoxin from Escherichia coli O78:H11 by affinity chromatography with antserum to Vibrio cholerae toxin.
    Dafni Z; Robbins JB
    J Infect Dis; 1976 Mar; 133 Suppl():138-41. PubMed ID: 768387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the in vitro early anamnestic antibody response by exogenous cholera enterotoxin and cyclic AMP.
    Cook RG; Stavitsky AB; Schoenberg MD
    J Immunol; 1975 Jan; 114(1 Pt 2):426-34. PubMed ID: 163858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gel filtration and ammonium sulphate precipitation in the purification of diphtheria toxin and toxoid.
    Møyner K; Christiansen G
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):17-23. PubMed ID: 6711307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
    Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralisation of the new cholera toxin by antiserum against crude enterotoxin of cholera toxin gene-positive Vibrio cholerae 01 in rabbit ileal loop model.
    Saha S; Sanyal SC
    Indian J Med Res; 1989 May; 89():117-20. PubMed ID: 2777342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.